サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1701277

バイオ医薬品製造用消耗品検査の市場規模、シェア、動向分析レポート：サービス別、原材料別、地域別、セグメント予測、2025年～2030年

Biopharmaceuticals Manufacturing Consumables Testing Market Size, Share & Trends Analysis Report By Service (Laboratory Testing, Custom Testing), By Raw Material (Formulation Excipients, API), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
バイオ医薬品製造用消耗品検査の市場規模、シェア、動向分析レポート：サービス別、原材料別、地域別、セグメント予測、2025年～2030年
出版日: 2025年03月03日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオ医薬品製造用消耗品検査市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のバイオ医薬品製造用消耗品検査市場規模は、2025年から2030年にかけて12.4%のCAGRを記録し、2030年には12億7,000万米ドルに達すると推定されています。

この市場を牽引しているのは、最終製品の迅速な上市を成功させるために原材料を詳細に評価する必要性が高まっていることです。バイオ医薬品業界における外部規制だけでなく、社内基準に関する意識の高まりも市場成長を後押ししています。

ここ数年、小さな化学分子から大きな生物学的分子へと大きなパラダイムシフトが起こっています。その結果、バイオ医薬品業界は、製造工程に関わるあらゆる側面を探求する方向に向かっています。

最高品質の原料や中間体に対する規制や品質への期待は高まり続けています。このため、賦形剤や原材料の製造に携わるベンダーは、最終製品開発者のニーズに一貫して対応するため、機能の標準化や洗練されたプロセスの確立に投資する必要に迫られています。

バイオ医薬品製造用消耗品検査市場レポートハイライト

  • サービス別では、コンペンディアル試験およびマルチコンペンディアル試験が最大のシェアを占めています。
  • 原料別では、原薬（API）分野が最大の売上シェアを占めたが、これは同分野に幅広いサービスが存在するためです。
  • 米国には多数の生物製剤製造企業が存在するため、2024年には北米が世界市場を独占することになります。競争企業間の敵対関係の高まりも、この地域の大きなシェアの要因となっています。
  • アジア太平洋地域は、予測期間中に大きなCAGRで成長すると予想され、その主な要因は、アジア諸国における受託サービス産業の拡大です。その一因は、これらの国々における低運営コストにあります。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 バイオ医薬品製造用消耗品検査市場の変数、動向、範囲

  • 市場系統の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • 業界分析- ポーターのファイブフォース分析
    • PESTLE分析

第4章 バイオ医薬品製造用消耗品検査市場：サービス別ビジネス分析

  • サービス別市場シェア、2024年と2030年
  • サービス別セグメントダッシュボード
  • サービス別市場規模、予測、動向分析（2018～2030年）
  • 臨床検査
  • カスタムテスト/顧客独自の検査
  • 公定書およびマルチ公定書に基づくラボ検査

第5章 バイオ医薬品製造用消耗品検査市場：原材料別ビジネス分析

  • 原材料別市場シェア、2024年と2030年
  • 原材料別セグメントダッシュボード
  • 原材料別市場規模、予測、動向分析（2018～2030年）
  • 製剤添加物
  • 医薬品有効成分（API）
  • 公定法（USP/EP/JP）に基づくベンダー適格性評価プログラムのサポート

第6章 バイオ医薬品製造用消耗品検査市場：地域原材料別推定・動向分析

  • 地域別市場シェア分析、2024年および2030年
  • 地域市場ダッシュボード
  • 市場規模、予測動向分析、2018年から2030年まで：
  • 北米
    • 国別、2018年～2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 国別、2018年～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 国別、2018年～2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • 国別、2018年～2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 国別、2018年～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 参入企業概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • Alcami Corporation
    • Merck KGaA
    • Eurofins Scientific
    • Agilent Technologies, Inc.
    • Charles River Laboratories.
    • Catalent, Inc
    • Element Materials Technology（Avomeen Analytical Services）
    • Pace Analytical Services, LLC
    • Nelson Laboratories, LLC（Gibraltar Laboratories）
図表

List of Tables

  • Table 1. List Of Secondary Sources
  • Table 2. List Of Abbreviations
  • Table 3. Global Biopharmaceuticals Manufacturing Consumables Testing Market, By Region, 2018 - 2030 (USD Million)
  • Table 4. Global Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 5. Global Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 6. North America Biopharmaceuticals Manufacturing Consumables Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 7. North America Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 8. North America Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 9. U.S. Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 10. U.S. Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 11. Canada Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 12. Canada Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 13. Mexico Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 14. Mexico Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 15. Europe Biopharmaceuticals Manufacturing Consumables Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 16. Europe Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 17. Europe Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 18. UK Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 19. UK Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 20. Germany Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 21. Germany Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 22. France Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 23. France Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 24. Italy Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 25. Italy Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 26. Spain Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 27. Spain Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 28. Denmark Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 29. Denmark Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 30. Sweden Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 31. Sweden Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 32. Norway Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 33. Norway Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific Biopharmaceuticals Manufacturing Consumables Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 36. Asia Pacific Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 37. Japan Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 38. Japan Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 39. China Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 40. China Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 41. India Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 42. India Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 43. Australia Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 44. Australia Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 45. South Korea Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 46. South Korea Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 47. Thailand Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 48. Thailand Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 49. Latin America Biopharmaceuticals Manufacturing Consumables Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 50. Latin America Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 51. Latin America Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 52. Brazil Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 53. Brazil Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 54. Argentina Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 55. Argentina Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa Biopharmaceuticals Manufacturing Consumables Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 58. Middle East & Africa Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 59. South Africa Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 60. South Africa Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 63. UAE Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 64. UAE Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)
  • Table 65. Kuwait Biopharmaceuticals Manufacturing Consumables Testing Market, By Service, 2018 - 2030 (USD Million)
  • Table 66. Kuwait Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Biopharmaceuticals Manufacturing Consumables Testing Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot
  • Fig. 9 Service and Raw Material Outlook (USD Million)
  • Fig. 10 Competitive Landscape
  • Fig. 11 Biopharmaceuticals Manufacturing Consumables Testing Market Dynamics
  • Fig. 12 Biopharmaceuticals Manufacturing Consumables Testing Market: Porter's Five Forces Analysis
  • Fig. 13 Biopharmaceuticals Manufacturing Consumables Testing Market: PESTLE Analysis
  • Fig. 14 Biopharmaceuticals Manufacturing Consumables Testing Market: Service Segment Dashboard
  • Fig. 15 Biopharmaceuticals Manufacturing Consumables Testing Market: Service Market Share Analysis, 2024 & 2030
  • Fig. 16 Laboratory Testing Market, 2018 - 2030 (USD Million)
  • Fig. 17 Custom Testing / Customer Proprietary Testing Market, 2018 - 2030 (USD Million)
  • Fig. 18 Compendial & Multi Compendial Laboratory Testing Market, 2018 - 2030 (USD Million)
  • Fig. 19 Biopharmaceuticals Manufacturing Consumables Testing Market: Raw Material Segment Dashboard
  • Fig. 20 Biopharmaceuticals Manufacturing Consumables Testing Market: Raw Material Market Share Analysis, 2024 & 2030
  • Fig. 21 Formulation Excipients Market, 2018 - 2030 (USD Million)
  • Fig. 22 Active Pharmaceutical Ingredients (API) Market, 2018 - 2030 (USD Million)
  • Fig. 23 Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support Market, 2018 - 2030 (USD Million)
  • Fig. 24 Biopharmaceuticals Manufacturing Consumables Testing Market Revenue, By Region
  • Fig. 25 Regional Marketplace: Key Takeaways
  • Fig. 26 Regional Marketplace: Key Takeaways
  • Fig. 27 North America Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 28 U.S. Country Dynamics
  • Fig. 29 U.S. Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 30 Canada Country Dynamics
  • Fig. 31 Canada Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 32 Mexico Country Dynamics
  • Fig. 33 Mexico Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 34 Europe Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 35 UK Country Dynamics
  • Fig. 36 UK Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 37 Germany Country Dynamics
  • Fig. 38 Germany Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 39 France Country Dynamics
  • Fig. 40 France Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 41 Italy Country Dynamics
  • Fig. 42 Italy Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 43 Spain Country Dynamics
  • Fig. 44 Spain Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 45 Norway Country Dynamics
  • Fig. 46 Norway Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden Country Dynamics
  • Fig. 48 Sweden Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 49 Denmark Country Dynamics
  • Fig. 50 Denmark Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 52 Japan Country Dynamics
  • Fig. 53 Japan Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 54 China Country Dynamics
  • Fig. 55 China Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 56 India Country Dynamics
  • Fig. 57 India Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 58 Australia Country Dynamics
  • Fig. 59 Australia Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 60 South Korea Country Dynamics
  • Fig. 61 South Korea Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 62 Thailand Country Dynamics
  • Fig. 63 Thailand Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 64 Latin America Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 65 Brazil Country Dynamics
  • Fig. 66 Brazil Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 67 Argentina Country Dynamics
  • Fig. 68 Argentina Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 69 MEA Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 70 South Africa Country Dynamics
  • Fig. 71 South Africa Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 72 Saudi Arabia Country Dynamics
  • Fig. 73 Saudi Arabia Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 74 UAE Country Dynamics
  • Fig. 75 UAE Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 76 Kuwait Country Dynamics
  • Fig. 77 Kuwait Biopharmaceuticals Manufacturing Consumables Testing Market, 2018 - 2030 (USD Million)
  • Fig. 78 Company Categorization
  • Fig. 79 Company Market Position Analysis
  • Fig. 80 Strategic Framework
目次
Product Code: GVR-2-68038-398-0

Biopharmaceuticals Manufacturing Consumables Testing Market Growth & Trends:

The global biopharmaceuticals manufacturing consumables testing market size is estimated to reach USD 1.27 billion by 2030, registering a CAGR of 12.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the growing need for an in-depth assessment of raw materials for the successful and rapid launch of the final product. Rising awareness pertaining to internal standards as well as external regulations in the biopharmaceutical industry is also aiding the market growth.

In the past few years, there has been a major paradigm shift from small chemical molecules to large biological molecules. As a result, the biopharmaceutical industry is geared toward exploring every aspect involved in the manufacturing process.

Regulatory and quality expectations for best quality raw materials and intermediates continue to increase. This, in turn, has pressurized vendors engaged in the manufacturing of excipients and raw materials to invest in standardizing functionality as well as establishing sophisticated processes to consistently address the needs of final product developers.

Biopharmaceuticals Manufacturing Consumables Testing Market Report Highlights:

  • Based on service, compendial and multi-compendial testing held the largest share, owing to demand from various manufacturers for raw materials that are compliant to regulatory standards.
  • Based on raw material, the active pharmaceutical ingredients (APIs) segment accounted for the largest revenue share, owing to the presence of a wide range of services in this segment.
  • Presence of a large number of biologics manufacturing entities in the U.S. has resulted in North America dominating the global market in 2024. Rising competitive rivalry amongst market participants is also attributive for the large share of this region.
  • Asia Pacific is expected to grow at a significant CAGR over the forecast period, fueled primarily by expansion of the contract service industry in several Asian countries. This is partly attributed to low operating costs in these nations.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Raw Material
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Biopharmaceuticals Manufacturing Consumables Testing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Biopharmaceuticals Manufacturing Consumables Testing Market: Service Business Analysis

  • 4.1. Service Market Share, 2024 & 2030
  • 4.2. Service Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Service, 2018 to 2030 (USD Million)
  • 4.4. Laboratory Testing
    • 4.4.1. Laboratory Testing Market, 2018 - 2030 (USD Million)
  • 4.5. Custom Testing / Customer Proprietary Testing
    • 4.5.1. Custom Testing / Customer Proprietary Testing Market, 2018 - 2030 (USD Million)
  • 4.6. Compendial & Multi Compendial Laboratory Testing
    • 4.6.1. Compendial & Multi Compendial Laboratory Testing Market, 2018 - 2030 (USD Million)

Chapter 5. Biopharmaceuticals Manufacturing Consumables Testing Market: Raw Material Business Analysis

  • 5.1. Raw Material Market Share, 2024 & 2030
  • 5.2. Raw Material Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Raw Material, 2018 to 2030 (USD Million)
  • 5.4. Formulation Excipients
    • 5.4.1. Formulation Excipients Market, 2018 - 2030 (USD Million)
  • 5.5. Active Pharmaceutical Ingredients (API)
    • 5.5.1. Active Pharmaceutical Ingredients (API) Market, 2018 - 2030 (USD Million)
  • 5.6. Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support
    • 5.6.1. Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support Market, 2018 - 2030 (USD Million)

Chapter 6. Biopharmaceuticals Manufacturing Consumables Testing Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Denmark Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Sweden Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Norway Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. Australia Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. South Korea Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Biopharmaceuticals Manufacturing Consumables Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Alcami Corporation
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Merck KGaA
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Eurofins Scientific
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Agilent Technologies, Inc.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Charles River Laboratories.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Catalent, Inc
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Element Materials Technology (Avomeen Analytical Services)
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Pace Analytical Services, LLC
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Nelson Laboratories, LLC (Gibraltar Laboratories)
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives